PBE vs. XPH ETF Comparison
Comparison of PowerShares Dynamic Biotech & Genome (PBE) to SPDR S&P Pharmaceuticals ETF (XPH)
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Grade (RS Rating)
Last Trade
$68.03
Average Daily Volume
6,342
30
XPH
SPDR S&P Pharmaceuticals ETF
XPH Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.Grade (RS Rating)
Last Trade
$45.97
Average Daily Volume
60,075
44
Performance
Period | PBE | XPH |
---|---|---|
30 Days | -0.98% | -2.44% |
60 Days | -5.20% | 1.87% |
90 Days | -4.17% | 5.00% |
12 Months | 20.11% | 26.54% |
1 Overlapping Holdings
Symbol | Grade | Weight in PBE | Weight in XPH | Overlap | |
---|---|---|---|---|---|
COLL | F | 2.27% | 1.48% | 1.48% |
PBE Overweight 29 Positions Relative to XPH
Symbol | Grade | Weight | |
---|---|---|---|
UTHR | C | 5.74% | |
ILMN | C | 5.64% | |
ALNY | D | 4.78% | |
AMGN | D | 4.7% | |
BIIB | F | 4.21% | |
NBIX | C | 4.18% | |
XNCR | B | 3.88% | |
EXEL | B | 3.86% | |
TGTX | B | 3.78% | |
BMRN | F | 3.76% | |
MNKD | B | 3.7% | |
NTRA | A | 3.56% | |
REGN | F | 3.38% | |
INCY | C | 3.35% | |
VCYT | B | 3.28% | |
ACAD | C | 3.06% | |
CPRX | C | 3.0% | |
BPMC | C | 2.91% | |
TECH | F | 2.89% | |
VCEL | A | 2.79% | |
OPK | B | 2.78% | |
RGEN | D | 2.76% | |
PTGX | D | 2.75% | |
QGEN | D | 2.59% | |
BCRX | D | 2.56% | |
HALO | F | 2.42% | |
CDNA | D | 1.92% | |
NVAX | F | 1.83% | |
MYGN | F | 1.61% |
PBE Underweight 43 Positions Relative to XPH
Symbol | Grade | Weight | |
---|---|---|---|
CORT | B | -4.96% | |
LBPH | A | -4.12% | |
BMY | B | -4.11% | |
ITCI | B | -4.01% | |
JAZZ | B | -3.94% | |
VTRS | A | -3.73% | |
AXSM | B | -3.59% | |
EWTX | C | -3.42% | |
CTLT | D | -3.41% | |
ELAN | D | -3.35% | |
PRGO | C | -3.35% | |
RPRX | D | -3.18% | |
JNJ | D | -3.17% | |
ZTS | D | -3.15% | |
PFE | F | -3.07% | |
LLY | F | -2.94% | |
MRK | F | -2.93% | |
TARS | C | -2.81% | |
OGN | F | -2.58% | |
SAVA | D | -2.57% | |
ARVN | F | -2.53% | |
PBH | A | -2.5% | |
SUPN | B | -2.15% | |
AMPH | F | -2.02% | |
PCRX | C | -1.91% | |
LGND | C | -1.77% | |
ANIP | D | -1.54% | |
OCUL | C | -1.44% | |
AMRX | C | -1.33% | |
MNMD | C | -1.23% | |
HRMY | F | -1.22% | |
WVE | C | -1.17% | |
HROW | D | -1.17% | |
INVA | D | -0.98% | |
EYPT | D | -0.94% | |
LQDA | F | -0.89% | |
PLRX | D | -0.87% | |
FULC | F | -0.85% | |
ELVN | C | -0.64% | |
NUVB | C | -0.6% | |
EOLS | F | -0.52% | |
PHAT | F | -0.48% | |
XERS | C | -0.46% |
PBE: Top Represented Industries & Keywords
XPH: Top Represented Industries & Keywords